We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Dual-Lead Nerve Stimulator Supports Pain Relief

By HospiMedica International staff writers
Posted on 03 Sep 2018
A new dual-lead percutaneous peripheral nerve stimulation (PNS) system helps reduce chronic and acute pain in the back and/or extremities for up to 60 days.

The SPR Therapeutics (Cleveland, OH, USA) Sprint Extensa dual lead PNS system is comprised of a lightweight wearable stimulator and a threadlike, flexible coiled lead only 0.2 mm in diameter. More...
The Sprint stimulator enables independent and efficient programming of stimulation parameters via Bluetooth connectivity, in order to deliver patient-specific, customized neurostimulation benefits, without requiring a permanent implant. Rechargeable batteries allow continuous stimulation delivery for the 60-day treatment period.

PNS is delivered via the MicroLead coiled lead, which is first placed percutaneously using a 20-gauge introducer, and then connected to the Sprint stimulator. Dual-lead capability allows two leads to be connected to a single wearable pulse generator. The lead has an open coiled structure with a barbed anchor at the distal end so as to reduce the risk of migration. The leads are placed during an outpatient procedure without surgery, incisions, tissue destruction, or anesthesia, and all device components are removed at the end of the treatment period.

“Our Sprint PNS platform is designed to deliver the least invasive and most user-friendly PNS therapy experience for physicians and their patients,” said Maria Bennett, founder, president, and CEO of SPR Therapeutics. “With the ease of use and dual lead capabilities we’ve built into the Sprint system, we look forward to advancing the early use of neurostimulation as a non-opioid alternative for more patients, while we continue to generate data that demonstrate significant and sustained pain relief following our 60-day therapy.”

“The Sprint PNS system provides a non-opioid therapy alternative that we have used successfully with many of our pain patients,” said Chris Gilmore, MD, of Carolinas Pain Institute in (Winston-Salem, NC, USA). “In my experience, most patients prefer a non-permanent, non-destructive, and non-surgical option for pain management when possible. The minimally invasive nature of the Sprint system allows us to introduce peripheral nerve stimulation therapy early in the care continuum, including its use in well-selected patients with back pain.”

PNS is a technique in which electrodes are placed along the course of peripheral nerves to control pain. Once the electrodes are in place, they are turned on to administer weak electrical currents to the nerve, experienced as a tingling sensation. By stimulating non-painful sensory pathway, the electrical current tricks the brain into attenuating pain signals (the so-called gate theory). PNS devices are an extremely safe, efficient, and effective way to ameliorate a variety of neuropathic pain conditions.

Related Links:
SPR Therapeutics


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Gas Consumption Analyzer
Anesthetic Gas Consumption Analyzer
Head Rest
Medifa 61114_3
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The AI-based approach identifies lipid regions matched well with histopathology results (Photo courtesy of Hyeong Soo Nam/KAIST)

AI-Based OCT Image Analysis Identifies High-Risk Plaques in Coronary Arteries

Lipid-rich plaques inside coronary arteries are strongly associated with heart attacks and other major cardiac events. While optical coherence tomography (OCT) provides detailed images of vessel structure... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.